Antiepileptic drugs and suicidality

Drug, Healthcare and Patient Safety

Volumn 2, Issue 1, 2010, Pages 181-189

  Britton, Jeffery W ^a   Shih, Jerry J ^b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Antiepileptic drugs; Behavior; FDA; Suicidality

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; FELBAMATE; GABAPENTIN; LAMOTRIGINE; LITHIUM; OXCARBAZEPINE; PRIMIDONE; SEROTONIN UPTAKE INHIBITOR; TIAGABINE; TOPIRAMATE; VALPROIC ACID;

ANXIETY; BIPOLAR DISORDER; CLINICAL ASSESSMENT; COMORBIDITY; DEPRESSION; DRUG DOSE ESCALATION; DRUG SAFETY; EPILEPSY; FAMILY; FOOD AND DRUG ADMINISTRATION; HUMAN; MENTAL DISEASE; PATIENT COUNSELING; PHQ 9; QUALITY OF LIFE IN EPILEPSY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SEIZURE; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SUICIDE; SUICIDE ATTEMPT;

EID: 78650693964     PISSN: None     EISSN: 11791365     Source Type: Journal    
DOI: 10.2147/DHPS.S13225     Document Type: Review

References (76)

1. Blisard KS, McFeeley PJ. The spectrum of neuropathologic findings in deaths associated with seizure disorders. J Forensic Sci. 1988;33:910-914.
2. Barooni S, Thambirajah Balachandra A, Lee L. Death in epileptic people: a review of Manitoba's medical examiner's cases. J Forensic Legal Med. 2007;14:275-278.
3. Jones JE, Hermann BP, Barry JJ, et al. Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy. Epilepsy Behav. 2003;4:S31-S38.
4. Nock MK, Borges G, Bromet EJ, et al. Suicide and suicidal behavior. Epidem Rev. 2008;30:133-154.
5. Karch DL, Dahlberg LL, Patel N, et al. Surveillance for violent deaths: national violent death reporting system, 16 States, 2006. MMWR Morb Mortal Wkly Rep Morbid Mort kly Rep. 2009;Surveillance Summaries. 58:1-44.
6. Prudhomme C. Epilepsy and suicide. J Nervous Mental Dis. 1941;94:722-731.
7. Henriksen B, Juul-Jensen P, Lund M. Mortality of epileptics. In: Brackenridge R, editor. Life Assurance Medicine. London, UK: Pitman Medical 1970:139-148.
8. Bell GS, Gaitatzis A, Bell CL, et al. Suicide in people with epilepsy: how great is the risk? Epilepsia. 2009;50:1933-1942.
9. Trivedi MH, Kurian BT. Managing depressive disorders in patients with epilepsy. Psychiatry. 2007;4:26-34.
10. Hitiris N, Mohanraj R, Norrie J, et al. Mortality in epilepsy. Epilepsy Behav. 2007;10:363-376.
11. Wada K, Iwasa H, Okada M, et al. Marital status of patients with epilepsy with special reference to the influence of epileptic seizures on the patient's married life. Epilepsia. 2004;45:33-36.
12. Sillanpaa M, Haataja L, Shinnar S. Perceived impact of childhoodonset epilepsy on quality of life as an adult. Epilepsia. 2004;45:971-977.
13. Keene DL, Loy-English I, Ventureyra EC. Long-term socioeconomic outcome following surgical intervention in the treatment of refractory epilepsy in childhood and adolescence. Child Nerv Sys. 1998;14:362-365.
14. Carran MA, Kohler CG, O'Connor MJ, et al. Marital status after epilepsy surgery. Epilepsia. 1999;40:1755-1760.
15. The RESt-1 Group. Social aspects of epilepsy in the adult in seven European countries. The RESt-1 Group. Epilepsia. 2000;41:998-1004.
16. Kalinin VV. Suicidality and antiepileptic drugs: is there a link? Drug Saf. 2007;30:123-142.
17. Mula M, Sander JW. Negative effects of antiepileptic drugs on mood in patients with epilepsy. Drug Saf. 2007;30:555-567.
18. Jacoby A, Johnson A, Chadwick D. Psychosocial outcomes of antiepileptic drug discontinuation. The Medical Research Council Antiepileptic Drug Withdrawal Study Group. Epilepsia. 1992;33:1123-1131.
19. Kilinc S, Campbell C. The experience of discontinuing antiepileptic drug treatment: an exploratory investigation. Seizure. 2008;17:505-513.
20. Gordon K, MacSween J, Dooley J, et al. Families are content to discontinue antiepileptic drugs at different risks than their physicians. Epilepsia. 1996;37:557-562.
21. FDA. Suicidality and Antiepileptic Drugs. 2008. Available from: http://www.fda.gov/cder/drug/infopage/antiepileptics/default.htm. Accessed on Jun 10, 2010.
22. Hauser WA, Annegers JF, Rocca WA. Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota. Mayo Clin Proceed. 1996;71:576-586.
23. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000;342:314-319.
24. Lawn ND, Bamlet WR, Radhakrishnan K, et al. Injuries due to seizures in persons with epilepsy: a population-based study. Am Acad Neurol. 2004;63:1565-1570.
25. Noe KH, Drazkowski JF. Safety of long-term video-electroencephalographic monitoring for evaluation of epilepsy. Mayo Clin Proceed. 2009;84:495-500.
26. Tellez-Zenteno JF, Ronquillo LH, Wiebe S. Sudden unexpected death in epilepsy: evidence-based analysis of incidence and risk factors. Epilepsy Res. 2005;65:101-115.
27. Sperling MR, Feldman H, Kinman J, et al. Seizure control and mortality in epilepsy. Ann Neurol. 1999;46:45-50.
28. Gilliam FG, Santos J, Vahle V, et al. Depression in epilepsy: ignoring clinical expression of neuronal network dysfunction? Epilepsia. 2004;45:28-33.
29. Boro A, Haut S. Medical comorbidities in the treatment of epilepsy. Epilepsy Behav. 2003;4:S2-S12.
30. Tellez-Zenteno JF, Patten SB, Jette N, et al. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia. 2007;48:2336-2344.
31. Schmitz B. Depression and mania in patients with epilepsy. Epilepsia. 2005;46:45-49.
32. Shneker BF, Cios JS, Elliott JO. Suicidality, depression screening, and antiepileptic drugs: reaction to the FDA alert. Neurology. 2009;72:987-991.
33. Dodrill CB, Batzel LW. Interictal behavioral features of patients with epilepsy. Epilepsia. 1986;27:S64-S76.
34. Kanner AM. Epilepsy, suicidal behaviour, and depression: do they share common pathogenic mechanisms? Lancet Neurol. 2006;5:107-108.
35. Mendez MF, Doss RC, Taylor JL, et al. Depression in epilepsy: relationship to seizures and anticonvulsant therapy. J Nerv Mental Dis. 1993;181:444-447.
36. Brent DA, Crumrine PK, Varma RR, et al. Phenobarbital treatment and major depressive disorder in children with epilepsy. Pediatrics. 1987;80:909.
37. Trimble MR, Rüsch N, Betts T, et al. Psychiatric symptoms after therapy with new antiepileptic drugs: psychopathological and seizure related variables. Seizure. 2000;9:249-254.
38. Mula M, Sander JW. Suicidal ideation in epilepsy and levetiracetam therapy. Epilepsy Behav. 2007;11:130-132.
39. Jacoby A, Baker GA, Steen N, et al. The clinical course of epilepsy and its psychosocial correlates: findings from a UK community study. Epilepsia. 1996;37:148-161.
40. O'Donoghue MF, Goodridge DM, Redhead K, et al. Assessing the psychosocial consequences of epilepsy: a community-based study. Br J Gen Pract. 1999;49:211-214.
41. Mula M, Trimble MR. The importance of being seizure free: topiramate and psychopathology in epilepsy. Epilepsy Behav. 2003;4:430-434.
42. Nilsson L, Tomson T, Farahmand BY, et al. Cause-specific mortality in epilepsy: a cohort study of more than 9,000 patients once hospitalized for epilepsy. Epilepsia. 1997;38:1062-1068.
43. Rafnsson V, Olafsson E, Hauser WA, et al. Cause-specific mortality in adults with unprovoked seizures. A population-based incidence cohort study. Neuroepidemiol. 2001;20:232-236.
44. Hauser WA, Annegers JF, Elveback LR. Mortality in patients with epilepsy. Epilepsia. 1980;21:399-412.
45. Lhatoo SD, Johnson AL, Goodridge DM, et al. Mortality in epilepsy in the first 11 to 14 years after diagnosis: Multivariate analysis of a long-term, prospective, population-based cohort. Ann Neurol. 2001;49:336-344.
46. Nilsson L, Ahlbom A, Farahmand BY, et al. Risk factors for suicide in epilepsy: a case control study. Epilepsia. 2002;43:644-651.
47. Christensen J, Vestergaard M, Mortensen PB, et al. Epilepsy and risk of suicide: a population-based case-control study. Lancet Neurol. 2007;6:693-698.
48. Mainio A, Alamaki K, Karvonen K, et al. Depression and suicide in epileptic victims: a population-based study of suicide victims during the years 1988-2002 in northern Finland. Epilepsy Behav. 2007;11:389-393.
49. Kalinin VV, Polyanskiy DA. Gender and suicidality prediction in epilepsy. Epilepsy Behav. 2005;7:657-663.
50. Fukuchi T, Kanemoto K, Kato M, et al. Death in epilepsy with special attention to suicide cases. Epilepsy Res. 2002;51:233-236.
51. Hesdorffer DC, Hauser WA, Olafsson E, et al. Depression and suicide attempt as risk factors for incident unprovoked seizures. Ann Neurol. 2006;59:35-41.
52. Avorn J. Drug warnings that can cause fits - communicating risks in a data-poor environment. N Engl J Med. 2008;359:991-994.
53. Levenson M, Mentari E, Hughes A, et al. Statistical review and evaluation: antiepileptic drugs and suicidality. In: Research CfDEa, editor.: Department of Health and Human Services 2008:1-45.
54. Hesdorffer DC, Kanner AM. The FDA alert on suicidality and antiepileptic drugs: fire or false alarm? Epilepsia. 2009;50:978-986.
55. Kanner AM, Cole AJ. Comorbid depressive disorders in epilepsy. CNS Spectr. 2010;15:3-6.
56. Bell GS, Mula M, Sander JW. Suicidality in people taking antiepileptic drugs: what is the evidence? CNS Drugs. 2009;23:281-292.
57. Olesen JB, Hansen PR, Erdal J, et al. Antiepileptic drugs and risk of suicide: a nationwide study. Pharmacoepidemiol Drug Safety. 2010;19:518-524.
58. Patorno E, Bohn RL, Wahl PM, et al. Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. JAMA. 2010;303:1401-1409.
59. Gibbons RD, Hur K, Brown CH, et al. Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder. Arch Gen Psychiatry. 2009;66:1354-1360.
60. van Cott AC, Cramer JA, Copeland LA, et al. Suicide-related behaviors in older patients with new anti-epileptic drug use: data from the VA hospital system. BMC Med. 2010;8:1-7.
61. Andersohn F, Schade R, Willich SN, et al. Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior. Neurology. 2010;75:335-340.
62. Porkorny A. Prediction of suicide in psychiatric patients: report of a prospective study. Arch Gen Psychiatry. 1983;40:249-257.
63. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. Eur Psychiatry. 1997;12:232-241.
64. Hockberger RS, Rothstein RJ. Assessment of suicide potential by nonpsychiatrists using the sad persons score. J Emergency Med. 1988;6:99-107.
65. Ebell MH. Screening instruments for depression. Am Fam Physician. 2008;78:244-246.
66. Gilbody S, Richards D, Brealey S, et al. Screening for depression in medical settings with the Patient Health Questionnaire (PHQ): a diagnostic meta-analysis. J Gen Int Med. 2007;22:1596-1602.
67. Spitzer RL, Kroenke K, Williams JBW. Patient health questionaire study group. Validity and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA. 1999;282:1737-1744.
68. Lo B. Informed consent. In Lo B, editor. Resolving Ethical Dilemmas: A guide for clinicians. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins 2005.
69. Guberman AH, Besag FM, Brodie MJ, et al. Lamotrigine-associated rash: risk/benefit considerations in adults and children. Epilepsia. 1999;40:985-991.
70. Harden CL. Therapeutic safety monitoring: what to look for and when to look for it. Epilepsia. 2000;41:S37-S44.
71. Pellock JM. Felbamate in epilepsy therapy: evaluating the risks. Drug Saf. 1999;21:225-239.
72. Nilsson L, Ahlbom A, Farahmand BY, et al. Mortality in a populationbased cohort of epilepsy surgery patients. Epilepsia. 2003;44:575-581.
73. Hepner KA, Rowe M, Rost K, et al. The effect of adherence to practice guidelines on depression outcomes. Ann Intern Med. 2007;147:320-329.
74. Luoma JB, Martin CE, Pearson JL. Contact with mental health and primary care providers before suicide: a review of the evidence. Am J Psychiatry. 2002;159:909-916.
75. Harden CL, Goldstein MA. Mood disorders in patients with epilepsy: epidemiology and management. CNS Drugs. 2002;16:291-302.
76. Prueter C, Norra C. Mood disorders and their treatment in patients with epilepsy. J Neuropsych Clin Neurosci. 2005;17:20-28.